Brazilian Journal of Pain
https://brjp.org.br/article/doi/10.63231/2595-0118.20250036-en
Brazilian Journal of Pain
Original Article

Effect of transcranial direct current stimulation on pain and mood in end-stage renal disease patients: a randomized clinical trial

Efeito da estimulação transcraniana por corrente contínua na dor e humor de pacientes renais em estágio terminal: ensaio clínico randomizado

Carla Daniele Ferreira Dantas; Artur Quintiliano; Edson Silva-Filho; Gianna Mastroianni Kirsztajn; Clecio Gabriel de Sousa; Rodrigo Pegado

http://dx.doi.org/10.63231/2595-0118.20250036-en BrJP, vol.8, e20250036, 2025
PDF English
PDF Português
SciELO
Downloads: 0
Views: 95

Abstract

BACKGROUND AND OBJECTIVES: Chronic kidney disease (CKD) is a significant public health concern. Patients affected by chronic kidney problems often experience symptoms, such as pain and mood disorders, while awaiting a transplant. Nonpharmacological interventions with no collateral effects are necessary for managing the symptoms. The objective of this study was to assess the effects of transcranial direct current stimulation (tDCS) on pain, anxiety, and depression in patients affected by CKD.

METHODS: This is a single-center, double-blinded, parallel, randomized sham-controlled clinical trial. The interventions consisted of ten non-consecutive sessions of anodal tDCS over the left dorsolateral prefrontal cortex and the cathode over the contralateral supraorbital region. Each session lasted 20 min with an intensity of 2 mA. This clinical trial included patients with CKD who experienced chronic pain and had been undergoing hemodialysis for more than three months. There were four assessments: at baseline, after the first and last intervention, and seven days after the last intervention (follow-up).

RESULTS: There was a significant interaction between group and time regarding pain (p=0.0005; partial η2 = 0.362) and a significant time interaction (p = 0.0005, partial η2 = 0.659) with significant differences between groups at day 10 (p= 0.004; partial η2 = 0.37) and follow-up (p= 0.03; partial η2 = 0.22). Additionally, there was a significant difference between groups for anxiety (p<0.02, partial η2= 0.258).

CONCLUSION: After ten sessions of tDCS, patients affected by chronic kidney disease showed a reduction in pain, anxiety, and depression

Keywords

Chronic pain; Hemodialysis; Neuromodulation; Noninvasive brain stimulation; Quality of life

Resumo

JUSTIFICATIVA E OBJETIVOS: A doença renal crônica (DRC) é uma preocupação significativa de saúde pública. Pacientes com problemas renais crônicos frequentemente apresentam sintomas como dor e transtornos do humor enquanto aguardam um transplante. Intervenções não farmacológicas, sem efeitos adversos, são necessárias para o manejo desses sintomas. O objetivo deste estudo foi avaliar os efeitos da estimulação transcraniana por corrente contínua (ETCC) na dor, ansiedade e depressão em pacientes com DRC.

MÉTODOS: Trata-se de um ensaio clínico randomizado, controlado por placebo, paralelo, duplo-cego e conduzido em um único centro. As intervenções consistiram em 10 sessões não consecutivas de ETCC anódica sobre o córtex pré-frontal dorsolateral esquerdo, com o cátodo posicionado sobre a região supraorbital contralateral. Cada sessão teve duração de 20 minutos, com intensidade de 2 mA. O ensaio clínico incluiu pacientes com DRC que apresentavam dor crônica e estavam em hemodiálise há mais de três meses. Foram realizadas quatro avaliações: na linha de base, após a primeira e última intervenção e sete dias após a última intervenção (follow-up).

RESULTADOS: Houve interação significativa entre grupo e tempo em relação à dor (p=0,0005; η2 parcial=0,362) e interação significativa com o tempo (p=0,0005; η2 parcial=0,659), com diferenças significativas entre os grupos no dia 10 (p=0,004; η2 parcial=0,37) e no follow-up (p=0,03; η2 parcial=0,22). Além disso, foi observada diferença significativa entre os grupos quanto à ansiedade.

CONCLUSÃO: Após 10 sessões de ETCC, pacientes com DRC apresentaram diminuição de dor, ansiedade e depressão.

Palavras-chave

Dor crônica; Estimulação cerebral não invasiva; Hemodiálise; Neuromodulação; Qualidade de vida

References

1 Samoudi AF, Marzouq MK, Samara AM, Zyoud SH, Al-Jabi SW. The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine. Health Qual Life Outcomes. 2021;19(1):39. http://doi.org/10.1186/s12955-021-01686-z. PMid:33531025.

2 Filipska A, Bohdan B, Wieczorek PP, Hudz N. Chronic kidney disease and dialysis therapy: incidence and prevalence in the world. Pharmacia. 2021;68(2):463-70. http://doi.org/10.3897/pharmacia.68.e65501.

3 Tobin DG, Lockwood MB, Kimmel PL, Dember LM, Eneanya ND, Jhamb M, Nolin TD, Becker WC, Fischer MJ. Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nat Rev Nephrol. 2022;18(2):113-28. http://doi.org/10.1038/s41581-021-00484-6. PMid:34621058.

4 Lambourg E, Colvin L, Guthrie G, Murugan K, Lim M, Walker H, Boon G, Bell S. The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis. Kidney Int. 2021;100(3):636-49. http://doi.org/10.1016/j.kint.2021.03.041. PMid:33940112.

5 Kandić M, Moliadze V, Andoh J, Flor H, Nees F. Brain circuits involved in the development of chronic musculoskeletal pain: evidence from non-invasive brain stimulation. Front Neurol. 2021;12:732034. http://doi.org/10.3389/fneur.2021.732034. PMid:34531819.

6 Elias MF, Dore GA, Davey A. Kidney disease and cognitive function. Contrib Nephrol. 2013;179:42-57. http://doi.org/10.1159/000346722. PMid:23652448.

7 Harciarek M, Williamson JB, Biedunkiewicz B, Lichodziejewska-Niemierko M, Dębska-Ślizień A, Rutkowski B. Risk factors for selective cognitive decline in dialyzed patients with end-stage renal disease: evidence from verbal fluency analysis. J Int Neuropsychol Soc. 2012;18(1):162-7. http://doi.org/10.1017/S1355617711001445. PMid:22088797.

8 Quintiliano A, Bikson M, Oehmen T, Pegado R, Kirsztajn GM. Transcranial Direct Current Stimulation (tDCS): pain management in end-stage renal disease - report of an early randomized controlled trial. J Pain Symptom Manage. 2022;64(3):234-43.e1. http://doi.org/10.1016/j.jpainsymman.2022.05.018. PMid:35640767.

9 O’Connell NE, Marston L, Spencer S, DeSouza LH, Wand BM. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2018;3(3):CD008208. PMid:29547226.

10 Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci. 2013;14(7):502-11. http://doi.org/10.1038/nrn3516. PMid:23719569.

11 Amidfar M, Ko YH, Kim YK. Neuromodulation and cognitive control of emotion. Adv Exp Med Biol. 2019;1192:545-64. http://doi.org/10.1007/978-981-32-9721-0_27. PMid:31705513.

12 Knotkova H, Nitsche MA, Bikson M, Woods AJ. Practical guide to transcranial direct current stimulation: principles, procedures and applications. Cham: Springer; 2019. http://doi.org/10.1007/978-3-319-95948-1.

13 Santoro D, Satta E, Messina S, Costantino G, Savica V, Bellinghieri G. Pain in end-stage renal disease: a frequent and neglected clinical problem. Clin Nephrol. 2013;79(Suppl 1):S2-11. PMid:23249527.

14 Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):834-40. http://doi.org/10.1016/j.jclinepi.2010.02.005. PMid:20346629.

15 Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713-35. http://doi.org/10.1053/j.ajkd.2014.01.416. PMid:24647050.

16 Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976-82. http://doi.org/10.1097/j.pain.0000000000001939. PMid:32694387.

17 Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res. 2011;63(S11, Suppl 11):S240-52. http://doi.org/10.1002/acr.20543. PMid:22588748.

18 Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5. http://doi.org/10.1111/j.2044-8341.1959.tb00467.x. PMid:13638508.

19 Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occup Med. 2015;65(7):601. http://doi.org/10.1093/occmed/kqv054. PMid:26370845.

20 Jackson-Koku G. Beck depression inventory. Occup Med. 2016;66(2):174-5. http://doi.org/10.1093/occmed/kqv087. PMid:26892598.

21 Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, Mourdoukoutas AP, Kronberg G, Truong D, Boggio P, Brunoni AR, Charvet L, Fregni F, Fritsch B, Gillick B, Hamilton RH, Hampstead BM, Jankord R, Kirton A, Knotkova H, Liebetanz D, Liu A, Loo C, Nitsche MA, Reis J, Richardson JD, Rotenberg A, Turkeltaub PE, Woods AJ. Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul. 2016;9(5):641-61. http://doi.org/10.1016/j.brs.2016.06.004. PMid:27372845.

22 Zhu CE, Yu B, Zhang W, Chen WH, Qi Q, Miao Y. Effectiveness and safety of transcranial direct current stimulation in fibromyalgia: A systematic review and meta-analysis. J Rehabil Med. 2017;49(1):2-9. http://doi.org/10.2340/16501977-2179. PMid:27983739.

23 Caravaca F, Gonzales B, Bayo MÁ, Luna E. Dolor músculo-esquelético en pacientes con enfermedad renal crónica. Nefrologia. 2016;36(4):433-40. http://doi.org/10.1016/j.nefro.2016.03.024. PMid:27267921.

24 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, clasification and stratification. Am J Kidney Dis. 2002;39(2, Suppl 1):S1-266.

25 Lowe KM, Robinson DR Jr. Pain management for patients with chronic kidney disease in the primary care setting. Nurse Pract. 2020;45(1):18-26. http://doi.org/10.1097/01.NPR.0000615544.81303.9c. PMid:31764241.

26 Hsu HJ, Yen CH, Hsu KH, Wu IW, Lee CC, Hung MJ, Sun CY, Chou CC, Chen YC, Hsieh MF, Chen CY, Hsu CY, Tsai CJ, Wu MS. Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease. BMC Nephrol. 2014;15(1):6. http://doi.org/10.1186/1471-2369-15-6. PMid:24400957.

27 Chen HJ, Zhang LJ, Lu GM. Multimodality MRI findings in patients with end-stage renal disease. BioMed Res Int. 2015;2015:697402. http://doi.org/10.1155/2015/697402. PMid:26064943.

28 Carswell C, Cogley C, Bramham K, Chilcot J, Noble H, Siddiqi N. Chronic kidney disease and severe mental illness: a scoping review. J Nephrol. 2023;36(6):1519-47. http://doi.org/10.1007/s40620-023-01599-8. PMid:37029882.

29 Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84(1):179-91. http://doi.org/10.1038/ki.2013.77. PMid:23486521.

30 Ong WY, Stohler CS, Herr DR. Role of the prefrontal cortex in pain processing. Mol Neurobiol. 2019;56(2):1137-66. http://doi.org/10.1007/s12035-018-1130-9. PMid:29876878.
 

Submitted date:
03/10/2025

Accepted date:
05/09/2025

6887c8efa953953a0f05796d brjp Articles
2595-3192 (Electronic) 2595-0118 (Printed)
BrJP ©2025 All rights reserved.

BrJP

Share this page
Page Sections